Glover Steve C

Director at Ambrx Biopharma Cayman, Inc. · on record since May 26, 2023
Director at AURIGA LABORATORIES, INC. · on record since Dec 13, 2006
President Follow-on Biologics at INSMED Inc · on record since Jun 2, 2008
Director at ONCOLYTICS BIOTECH INC · on record since Jun 3, 2026
SVP Brand Operations at ANDRX CORP /DE/ · on record since Sep 30, 2004
Director at PDS Biotechnology Corp · on record since Apr 10, 2019
Director at ZyVersa Therapeutics, Inc. · on record since Dec 14, 2022
Chief Executive Officer at ZyVersa Therapeutics, Inc. · on record since Dec 14, 2022

Insider trading activity of Glover Steve C

Transactions on record: 52; since Nov 23, 2004

Open-market buys: 7; $138K

Open-market sells: 0

Companies traded: 8; last filing Jun 3, 2026

Figures computed from official regulatory filings — .

Companies where Glover Steve C has traded

ONCOLYTICS BIOTECH INC1 tx · Jun 3, 2026
PDS Biotechnology Corp12 tx · $124.9K · Mar 3, 2026
ZyVersa Therapeutics, Inc.16 tx · Jul 15, 2025
Ambrx Biopharma, Inc.4 tx · Mar 7, 2024
Ambrx Biopharma Cayman, Inc.4 tx · Jun 9, 2023
INSMED Inc13 tx · $400.4K · Apr 2, 2009
AURIGA LABORATORIES, INC.1 tx · Dec 12, 2006
1 tx · Nov 23, 2004

Track record of Glover Steve C

Statistical track record

Free account

Open-market buys: 8

Last buy: Feb 28, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Glover Steve C

Co-insiders of Glover Steve C

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ONCOLYTICS BIOTECH INCListing on record	Jun 3, 2026	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Mar 3, 2026	AwardD (derivative)	54,876	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Jul 15, 2025	AwardD (derivative)	136,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Jun 11, 2025	AwardD (derivative)	22,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Mar 3, 2025	Buy	15,061	1.66 USD	$25K	conv 54First in 12mo	SEC
PDS Biotechnology CorpListing on record	Mar 3, 2025	BuyD (derivative)	15,061	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
ZyVersa Therapeutics, Inc.Listing on record	Jul 18, 2024	AwardD (derivative)	1,627	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Jun 25, 2024	AwardD (derivative)	9,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-12,142	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-5,714	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-2,500	—	n/a (No price was disclosed in the filing)		SEC
PDS Biotechnology CorpListing on record	Jul 17, 2023	AwardD (derivative)	9,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jun 9, 2023	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jun 9, 2023	Award	85,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jun 9, 2023	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	May 26, 2023	AwardD (derivative)	210,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	168,761	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	1,750	—	n/a (No price was disclosed in the filing)		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	3,022	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	17,903	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	138,980	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	264,838	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	Award	43,847	—	n/a (No price was disclosed in the filing)		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	Award	448,909	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ONCOLYTICS BIOTECH INCListing on record	Jun 3, 2026	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Mar 3, 2026	AwardD (derivative)	54,876	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Jul 15, 2025	AwardD (derivative)	136,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Jun 11, 2025	AwardD (derivative)	22,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Mar 3, 2025	Buy	15,061	1.66 USD	$25K	conv 54First in 12mo	SEC
PDS Biotechnology CorpListing on record	Mar 3, 2025	BuyD (derivative)	15,061	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
ZyVersa Therapeutics, Inc.Listing on record	Jul 18, 2024	AwardD (derivative)	1,627	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PDS Biotechnology CorpListing on record	Jun 25, 2024	AwardD (derivative)	9,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-12,142	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-5,714	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-2,500	—	n/a (No price was disclosed in the filing)		SEC
PDS Biotechnology CorpListing on record	Jul 17, 2023	AwardD (derivative)	9,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jun 9, 2023	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jun 9, 2023	Award	85,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jun 9, 2023	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	May 26, 2023	AwardD (derivative)	210,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	168,761	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	1,750	—	n/a (No price was disclosed in the filing)		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	3,022	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	17,903	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	138,980	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	AwardD (derivative)	264,838	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	Award	43,847	—	n/a (No price was disclosed in the filing)		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	Award	448,909	—	n/a (No price was disclosed in the filing)		SEC